High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease

Abstract

In Cushing's disease, invasive macroadenomas including CCA usually have low-MGMT expression. Temozolomide thus may be a new therapeutic option for invasive macroadenomas such as CCA particularly when conventional treatments are ineffective.